Cumberland Pharmaceuticals Reports 6% Revenue Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Cumberland Pharmaceuticals (CPIX) Tops Q1 EPS by 3c
May 10, 2022 5:05 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.19 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More